home / stock / immvf / immvf short
Short Information | Immunovia AB (OTCMKTS:IMMVF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 8,706 |
Total Actual Volume | 10,311 |
Short Trends | |
---|---|
Cover Days | 1 |
Short Days | 16 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 435 |
Average Short Percentage | 79.20% |
Is there a IMMVF Short Squeeze or Breakout about to happen?
See the IMMVF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-19-2022 | $3.18 | $3.18 | $3.18 | $3.18 | 600 | 300 | 50% |
07-13-2022 | $2.97 | $3 | $3 | $2.97 | 895 | 400 | 44.69% |
07-12-2022 | $3.04 | $3.04 | $3.04 | $3.04 | 400 | 400 | 100% |
07-07-2022 | $2.96 | $2.96 | $2.96 | $2.96 | 100 | 100 | 100% |
03-24-2022 | $4.001 | $4.001 | $4.001 | $4.001 | 375 | 375 | 100% |
03-23-2022 | $4 | $4 | $4 | $4 | 100 | 100 | 100% |
03-16-2022 | $4.12 | $4.12 | $4.12 | $4.12 | 180 | 180 | 100% |
02-25-2022 | $3.65 | $3.65 | $3.65 | $3.65 | 1,400 | 1,400 | 100% |
12-22-2021 | $7.81 | $7.4 | $7.81 | $7.4 | 400 | 100 | 25% |
12-06-2021 | $8.58 | $8.58 | $8.58 | $8.58 | 410 | 400 | 97.56% |
11-09-2021 | $13.95 | $13.95 | $13.95 | $13.95 | 400 | 400 | 100% |
07-06-2021 | $11.7 | $11.7 | $11.7 | $11.7 | 251 | 251 | 100% |
07-01-2020 | $17.95 | $17.95 | $17.95 | $17.95 | 1,000 | 1,000 | 100% |
06-29-2020 | $16 | $16 | $16 | $16 | 500 | 500 | 100% |
06-10-2020 | $14.7405 | $14.7405 | $14.7405 | $14.7405 | 1,500 | 1,000 | 66.67% |
12-18-2019 | $N/A | $18.15 | $N/A | $N/A | 1,000 | 1,000 | 100% |
07-26-2019 | $18.15 | $18.15 | $18.15 | $18.15 | 500 | 500 | 100% |
07-12-2019 | $18.80 | $18.80 | $18.80 | $18.80 | 300 | 300 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Immunovia AB Company Name:
IMMVF Stock Symbol:
OTCMKTS Market:
Immunovia Publishes Interim Report for January-March 2023 PR Newswire LUND, Sweden , May 23, 2023 /PRNewswire/ -- January- March 2023 Net sales amounted to kSEK 520 (182) divided by sales of tests kSEK 379 (122) and royalties kSEK 141(60). N...
Immunovia, Inc. market access increases when achieving Clinical Laboratory Permits from Pennsylvania and Maryland Departments of Health making IMMray™ PanCan-d test available in 48 US states PR Newswire LUND, Sweden , May 23, 2022 /PRNewswire/ -- T...
Immunovia reiterates its road to reimbursement for the IMMray™ PanCan-d test PR Newswire LUND, Sweden , April 22, 2021 /PRNewswire/ -- Immunovia is launching its IMMray™ PanCan-d test in the US as a Laboratory Developed Test (LDT) in Q2 2021. The ...